Manufactured by Roche Diabetes Care – the audible and/or vibration alarms might not function, which may lead to hyperglycaemia if the user doesn’t see the notification message on the pump.
- Identify all users of Accu-Chek Insight insulin pumps
- Ensure that all patients and carers:
- receive the manufacturer’s Field Safety Notice (FSN)
- understand the information detailed in the FSN and follow the advice given by the manufacturer
- check the display of the insulin pump regularly
- seek clinical advice if they are concerned and have an alternative insulin therapy available if necessary
- contact Roche Careline to get a replacement if the pump continues to display the ‘E7’ error message
- Return the FSN acknowledgment form to Roche as currently the manufacturer has not received sufficient responses
- All healthcare workers responsible for patients who use these devices
- Diabetes departments
Deadlines for actions
Actions underway: 4 October 2017
Actions complete: 18 October 2017
Problem / background
Due to an electrical issue there is a risk of a vibrator alarm failure and an intermittent audible alarm failure.
The alarm failures will be detected during a pump’s self-test, which is prompted by changing the battery or insulin cartridge. If the failures are detected, the E7 error shows on the pump’s display.
Users should contact the customer careline as instructed in the user manual if they cannot resolve an E7 error message.
Roche Diabetes Care
Tel: 0800 731 2291
Manufacturer FSCA Reference: SB_RDC_2017_04
If you are responsible for cascading these alerts in your organisation, these are our suggested distribution lists.
Trusts (NHS boards in Scotland)
CAS and NICAS liaison officers for onward distribution to all relevant staff including:
- Community diabetes specialist nurses
- Community hospitals
- Diabetes clinics/outpatients
- Diabetes nurse specialists
- Diabetes, directors of
- EBME departments
- Outpatient clinics
- Medical libraries
- Paediatric diabetes nurse specialists
- Paediatric wards
- Paediatrics departments
- Risk managers
- Supplies managers
NHS England area teams
CAS liaison officers for onward distribution to all relevant staff including:
- Community pharmacists
- General practice managers
- General practice nurses
- General practitioners
This Medical Device Alert is being sent to GPs for information only, in circumstances where patients may seek advice about the contents of this notice. GPs need take no further action on receipt of this alert.
Establishments registered with the Care Quality Commission (CQC) (England only)
- Hospitals in the independent sector
- Independent treatment centres
- Private medical practitioners
Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: email@example.com and requesting this facility.
Send enquiries about this notice to MHRA, quoting reference number MDA/2017/030 or 2017/007/025/291/019.
Anna Biela and Jennifer Hannon, MHRA
Tel: 020 3080 6649 / 7153
Devices Clinical Team, MHRA
Tel: 020 3080 7274
Reporting adverse incidents in England
Alerts in Northern Ireland are distributed via the NI SABS system.
Enquiries and adverse incident reports in Northern Ireland should be addressed to:
Northern Ireland Adverse Incident Centre, CMO Group,
Department of Health, Social Services and Public Safety
Tel: 028 9052 3868
Please report directly to NIAIC using the forms on our website.
Enquiries and adverse incident reports in Scotland should be addressed to:
Incident Reporting and Investigation Centre,
Health Facilities Scotland,
NHS National Services Scotland
Tel: 0131 275 7575
Fax: 0131 314 0722
Reporting adverse incidents in Scotland
NHS Boards and Local Authorities in Scotland – report to Health Facilities Scotland.
Contractors such as private hospitals carrying out NHS work and private care homes that accept social work funded clients – report to Health Facilities Scotland.
Enquiries in Wales should be addressed to:
Healthcare Quality Division,
Tel: 02920 823 624 / 02920 825 510